Additionally, a clinical study examined immunohistochemistry from paired normal and tumour tissue in hepatocellular carcinoma and discovered BCL-3 expression resulted in advanced Tumour, Node, Metastasis stage; this was shown to have contributed to the poorer prognosis observed in these patients (43). This evidence concerns the gene BCL3 and hepatocellular carcinoma.